Overview Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension Status: Completed Trial end date: 2012-02-01 Target enrollment: Participant gender: Summary To investigate the safety and efficacy of DE-112 in lowering intraocular pressure in subjects with primary open-angle glaucoma or ocular hypertension. Phase: Phase 1/Phase 2 Details Lead Sponsor: Santen Inc.Treatments: Maleic acidOphthalmic SolutionsPharmaceutical SolutionsTimolol